Table 1.
Group 1 ≤ 6 hrs (n=99) | Group 2 > 6 hrs (n=36) | Pvalue | |
---|---|---|---|
Age (months) | 26.37 ± 30.89 | 18.5 ± 26.2 | 0.019 |
Sex (male) | (56.56%) | (50%) | 0.7869 |
Weight (kg) | 7.85 ± 4.14 | 6.38 ± 3.68 | 0.005 |
Malnutrition | 88 (87.8%) | 32 (91.6%) | 0.808 |
Trisomy 21 (n, %) | 2 (3%) | 7 (16.6%) | 0.015 |
Type of VSD | |||
Perimembranous (n, %) | 68 (68.6%) | 20 (55.5%) | 0.225 |
Subaortic (n, %) | 19 (19.1%) | 10 (27.7%) | 0.402 |
Muscular (n, %) | 12 (12.1%) | 6 (16.6%) | 0.688 |
Size of VSD | |||
Small VSD (n, %) | 24 (25.2%) | 7 (16.6%) | 0.802 |
Moderate VSD (n, %) | 4 (4.04%) | __ | 0.533 |
Large VSD (n, %) | 72 (70.7%) | 28 (83.3%) | 0.480 |
PAH | |||
Mild PAH (n, %) | 20 (21.21%) | 3 (5.5%) | 0.198 |
Moderate PAH (n, %) | 10 (10.10%) | 3 (8.3%) | 0.931 |
Severe PAH (n, %) | 70 (68.68%) | 29 (86.1%) | 0.208 |
Lesions | |||
Single VSD (n, %) | 80 (79.79%) | 23 (66.6%) | 0.139 |
Multiple VSD (n, %) | 5 (5.05%) | 7 (19.4%) | 0.019 |
VSD+PDA (n, %) | 3 (3.03%) | 1 (2.7%) | 0.618 |
VSD+ASD (n, %) | 12 (12.12%) | 4 (11.1%) | 0.888 |
VSD=ventricular septal defect; ASD=atrial septal defect; PAH=pulmonary arterial hypertension; PDA=patent ductus arteriosus